According to the World Health Vaccinations (WHO), reported that none of the candidate vaccines have cleared the advanced clinical trials so far. There has been no such “clear signal” of efficiency at the level of 50%, which is put forward by the WHO. On Friday, a spokesperson of the WHO reported certain points which mainly stressed upon the fact of how rigorous check-ups are important for the effectiveness and safety of the public.
Russia had put out its Covid-19 vaccine in August after testing it for less that 2 months, this provoked many Western experts to question the vaccine’s safety and efficiency. The election for US President will be conducted on November 2, and lately it was announced by the US Public Health officials and Pfizer Inc that the covid-19 vaccine will be ready for distribution till late October. This will help Donald Trump to also win a second term.
In a briefing at Geneva, Margaret Harris-spokesperson of WHO said that, “We are really not expecting to see widespread vaccination until the middle of next year. This phase 3 must take longer because we need to see how truly protective the vaccine is and we also need to see how safe it is.” The statements made were referred to the phase in vaccine research where large clinical trials among people are conducted.
The vaccine candidates keep the WHO updated about the data received from trials. The data received from various trials are shared and compared for which Harris said, “A lot of people have been vaccinated and what we don’t know is whether the vaccine works…at this stage we do not have the clear signal of whether or not it has the level of worthwhile efficacy and safety…”
COVAX- a leading global vaccine allocation plan which is built in collaboration with WHO and GAVI. The aim of this vaccine is to help buy and distribute the vaccine shots fairly. Healthcare workers are targeted as they are at the highest risk in every country. COVAX aims to provide 2 billion doses of approved vaccine by the end of 2021.
Harris added at the end, “Essentially, the door is open. We are open. What the COVAX is about is making sure everybody on the planet will get access to the vaccines.”
It is believed that even if the coronavirus vaccine is developed it will not help to curb the virus completely, rather it will prolong the virus.
NEWS REPORTED BY:
VRIDHI BHAGNARI.
